Pdb40 - Impact of Dapagliflozin on Reducing Economic Burden of Type 2 Diabetes &Enhancement Patient’s Outcomes at Countries With High Incidence of Diabetes Egypt Case

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.746
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pdb104 - Impact of Dapagliflozin on Reducing Economic Burden of Diabetes in Egypt

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PDB40 Economic Burden of Type 2 Diabetes Mellitus in China

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Impact of Intervention on Metabolic Outcomes Among Dropouts With Type 2 Diabetes

Advances in Medical Sciences
Medicine
2018English

Practice of Dapagliflozin Application in Patients With Type 2 Diabetes Mellitus

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY
2015English

Economic Burden of Moderate Chronic Kidney Disease in Type 2 Diabetes

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Estimated Lifetime Economic Burden of Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Impact of Music on Type 2 Diabetes

International Journal of Diabetes & Metabolic Disorders
2016English

High-Density Lipoprotein Function Is Associated With Atherosclerotic Burden and Cardiovascular Outcomes in Type 2 Diabetes

Atherosclerosis
Cardiovascular MedicineCardiology
2019English

Pnd157 - Enhancement for Stroke Patient’s Outcomes. Egypt Model

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy